Cronos Group Reports 2025 Second Quarter Results
Net revenue in Q2 2025 increased by 21% year-over-year
Latest earnings news and updates for US-listed public companies.
Net revenue in Q2 2025 increased by 21% year-over-year
COLUMBIA, S.C.--(BUSINESS WIRE)--United Homes Group, Inc. (the âCompanyâ) (NASDAQ: UHG) today announced results for the three and six months ended June 30, 2025. Second Quarter 2025 Operating Resul...
ASHEVILLE, N.C.--(BUSINESS WIRE)---- $IMKTA--Ingles Markets, Incorporated (NASDAQ: IMKTA) today reported results for the three and nine months ended June 28, 2025. Robert P. Ingle II, Chairman of t...
ALBANY, N.Y.--(BUSINESS WIRE)---- $SLNH #SLNH--Soluna Holdings, Inc. (âSolunaâ or the âCompanyâ), (NASDAQ: SLNH), a developer of green data centers for intensive computing applications, including B...
LONDON--(BUSINESS WIRE)---- $SLN #SenseofSilence--Silence Therapeutics plc, Nasdaq: SLN (âSilenceâ or âthe Companyâ), a global clinical-stage company developing novel siRNA (short interfering RNA) ...
HOUSTON--(BUSINESS WIRE)--Cheniere Reports Second Quarter 2025 Results and Updates Full Year 2025 Financial Guidance
COLUMBUS, Ohio--(BUSINESS WIRE)--Installed Building Products, Inc. (the "Company" or "IBP") (NYSE: IBP), an industry-leading installer of insulation and complementary building products, today annou...
TROY, Mich., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Kelly (Nasdaq: KELYA, KELYB), a leading specialty talent solutions provider, today announced results for the second quarter of 2025.
â Registrational cohort enrollment in RESET-Myositisâą trial on track to start in 2H25 with anticipated 2027 BLA submission for rese-cel in myositis â
PRINCETON, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the âCompanyâ or âY-mAbsâ) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development an...